Part, Chapter, Paragraph
1 II, 5. 5. 3| the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~Andlin-Sobocki
2 II, 5. 5. 3| disorders in Europe. Eur J Neurol 12 Suppl 1:74-77.~Andrews
3 II, 5. 5. 3| prevalence, and prognosis. J Neurol Neurosurg Psychiatry 58:
4 II, 5. 5. 3| systematic review. Eur J Neurol 12:245-253.~Fraser RT, Clemmons
5 II, 5. 5. 3| with epilepsy’ Curr Opin Neurol 17:141-146.~Kotsopoulos
6 II, 5. 5. 3| prospectively over 11-14 years. J Neurol Neurosurg Psychiatry 71:
7 II, 5. 5. 3| associated health usage. J Neurol Neurosurg Psychiatry 69:
8 II, 5. 5. 3| sudden death in epilepsy. J Neurol Neurosurg Psychiatry 60:
9 II, 5. 5. 3| prospective study. Lancet Neurol 4:627-634.~Osservatorio
10 II, 5. 5. 3| drivers with epilepsy. J Neurol Neurosurg Psychiatry 60:
11 II, 5. 5. 3| Mures County, Romania. Rom J Neurol Psychiatry 32:115-122.~Bencsik
12 II, 5. 5. 3| Csongrád County, Hungary. Eur Neurol 46:206-209.~Benedikz J,
13 II, 5. 5. 3| Móstoles, central Spain. Acta Neurol Scand 98:238-242.~Berkowicz
14 II, 5. 5. 3| and genetic factors. Acta Neurol Scand 91(Suppl 161):71-76.~
15 II, 5. 5. 3| a 25-year period. Eur J Neurol 8:463-469.~Confavreux C,
16 II, 5. 5. 3| for multiple sclerosis. J Neurol Neurosurg Psychiatr 55:671–
17 II, 5. 5. 3| sclerosis registers – EDMUS. Ann Neurol 36(suppl):S136–S139.~Confavreux
18 II, 5. 5. 3| and incidence study. Acta Neurol Scand 109:378-384.~De Sã
19 II, 5. 5. 3| of Santarem, Portugal. J Neurol 253:914-918.~Dean G, Elian
20 II, 5. 5. 3| Malta in 1999: an update. J Neurol Neurosurg Psychiatry 73;
21 II, 5. 5. 3| trends, and prospects. Eur J Neurol 11:511–520~EUROPA. The EU
22 II, 5. 5. 3| McDonald criteria. Acta Neurol Scand 109:385-389.~Firnhaber
23 II, 5. 5. 3| gradients really exist? J Neurol 246:1033–1040.~Ford HL,
24 II, 5. 5. 3| Leeds Health Authority. J Neurol Neurosurg Psychiatry 64:
25 II, 5. 5. 3| multiple sclerosis in Leeds. J Neurol 249:260-265.~Fox-Rushby
26 II, 5. 5. 3| prevalence in Ferrara. Arch Neurol 53:793-798.~Gross K, Kokk
27 II, 5. 5. 3| Fennoscandian focus. Acta Neurol Scand 88:241-246.~Grytten
28 II, 5. 5. 3| indigeneous population. J Neurol 247;129-133.~Haffenden S,
29 II, 5. 5. 3| Multiple Sclerosis Society. Eur Neurol. 2006;56(2):78-105~Horakova
30 II, 5. 5. 3| Sclerosis Registry. Acta Neurol Scand 78:369–380.~Koch-Henriksen
31 II, 5. 5. 3| multiple sclerosis. Arch Neurol 45:435-437.~Kurtzke JF (
32 II, 5. 5. 3| Northern Ireland, UK. J Neurol Neurosurg Psychiatry 64:
33 II, 5. 5. 3| of genetic diversity. J Neurol Neurosurg Psychiatry 75:
34 II, 5. 5. 3| Multiple sclerosis in Cyprus. J Neurol Sci 103:29-36.~Milanov I,
35 II, 5. 5. 3| province of Teruel, Spain. J Neurol 244:182-185.~Mor u T, eaManceau
36 II, 5. 5. 3| population-based ascertainment. Neurol Res 22:156-159.~MSTCG (Multiple
37 II, 5. 5. 3| practice and research. Acta Neurol Scand 183(Suppl):37-40.~
38 II, 5. 5. 3| Croatia and Slovenia. J Neurol Sci 247:169-172.~Piperidou
39 II, 5. 5. 3| province of Evros, Greece. Eur Neurol 49:8-12.~Poser CM, Paty
40 II, 5. 5. 3| and incidence 1993-1995. Neurol Neurochir Pol 33:575-585.~
41 II, 5. 5. 3| true increasing risk. Acta Neurol Scand 103:20-26~Pugliatti
42 II, 5. 5. 3| sclerosis in Europe. Eur J Neurol 13: 700–722.~Pugliatti M,
43 II, 5. 5. 3| districts of East Anglia. J Neurol Neurosurg Psychiatry 59:
44 II, 5. 5. 3| genetic predisposition. J Neurol Neurosurg Psychiatry 64:
45 II, 5. 5. 3| critical overview. Can J Neurol Sci 20:17-29.~Sarasoja T,
46 II, 5. 5. 3| comparison during 30 years. Acta Neurol Scand 110: 331–336.~Sobocki
47 II, 5. 5. 3| sclerosis in Finland. Acta Neurol Scand 103:153-158.~Sumelahti
48 II, 5. 5. 3| progressive disease courses. J Neurol Neurosurg Psychiatry 74:
49 II, 5. 5. 3| in northern Sweden. Acta Neurol Scand 103:214-218.~Sundström
50 II, 5. 5. 3| County in northern Sweden. J Neurol Neurosurg Psychiatry 74:
51 II, 5. 5. 3| County in northern Sweden. J Neurol Neurosurg Psychiatry 75;
52 II, 5. 5. 3| Valladolid, northern Spain. J Neurol 246:170-174.~Totaro R, Marini
53 II, 5. 5. 3| district, central Italy. J Neurol Neurosurg Psychiat 68:349-
54 II, 5. 5. 3| sclerosis in French farmers. J Neurol Neurosurg Psychiatry 78:
55 II, 5. 5. 3| the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~Baldereschi
56 II, 5. 5. 3| in Parkinson's disease. J Neurol Sci. 262:37-44.~Errea JM,
57 II, 5. 5. 3| for Parkinson’s disease. J Neurol Sci 217(2):169-174.~Granieri
58 II, 5. 5. 3| 1967 through 1987. Arch Neurol 48(8):854-857.~Hely MA,
59 II, 5. 5. 3| and post-levodopa eras. Neurol Clin 10(2):331-339.~Horstink
60 II, 5. 5. 3| Parkinson’s disease. Eur J Neurol 13(11):1170-1185.~Hughes
61 II, 5. 5. 3| disease in Europe. Eur J Neurol 12 Suppl 1:68-73.~Logroscino
62 II, 5. 5. 3| Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psych 76(4):498-
63 II, 5. 5. 3| parkinsonian patients. Psychiatr Neurol Med Psychol:385-394.~Spottke
64 II, 5. 5. 3| Evidence from twin studies. Adv Neurol 91:133-142.~Twelves D, Perkins
65 II, 9. 1. 1| registers. Dev Med Child Neurol 2000;42(12):816-24.~ ~Stephenson
66 II, 9. 3. 2| registers. Dev Med Child Neurol 2000;42(12):816-24.~ ~Temmerman
67 IV, 13. 9 | the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~EPC (Economic
